SCHEMBL3416366

SCHEMBL3416366

COc1ccc(-c2ccc(OC)c(C(=O)O)c2)cc1CNC(=O)c1sc(-c2ccc(Cl)cc2Cl)nc1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.45
RECQL P46063 1/20 0.45
MAPT P10636 7/20 0.44
KDM4E B2RXH2 2/20 0.44
PPARA Q07869 3/20 0.44
PPARD Q03181 2/20 0.44
TP53 P04637 2/20 0.42
HPGD P15428 1/20 0.42
GAA P10253 1/20 0.42
LMNA P02545 2/20 0.41
THRB P10828 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CTSA P10619 2/20 0.41
ROCK2 O75116 1/20 0.41
ROCK1 Q13464 1/20 0.41
PPARG P37231 1/20 0.40
NPC1 O15118 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
POLB P06746 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6865441 0.91 PPARA (0.45) MAPTKDM4EPPARAPPARDHPGD
SCHEMBL3418419 0.91 PPARA (0.54) TSHRRECQLMAPTKDM4EPPARA
SCHEMBL3416696 0.90 PPARA (0.54) MAPTKDM4EPPARAPPARDTHRB
SCHEMBL13460926 0.88 PPARA (0.42) TSHRRECQLMAPTKDM4EPPARA
SCHEMBL3419218 0.86 PPARA (0.51) MAPTKDM4EPPARAPPARDHPGD
SCHEMBL13433239 0.85 PPARA (0.47) MAPTKDM4EPPARAPPARDTP53
SCHEMBL3416072 0.84 HPGD (0.51) MAPTPPARAPPARDHPGDGAA
SCHEMBL3413992 0.83 PPARA (0.54) MAPTKDM4EPPARAPPARDTP53
SCHEMBL3413880 0.83 SMN1; SMN2 (0.50) TSHRRECQLMAPTKDM4EPPARA
SCHEMBL3413268 0.82 PPARA (0.51) MAPTKDM4EPPARAPPARDTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7687664-B2 Carboxylic acid derivative, a salt thereof or an ester of them, and medicament comprising it EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-03-30 US disclosed
US-7687664-B2 Carboxylic acid derivative, a salt thereof or an ester of them, and medicament comprising it EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-03-30 US disclosed
US-20040214888-A1 Carboxylic acid derivative and medicine comprising salt or ester of the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-10-28 US disclosed
EP-1394147-A1 CARBOXYLIC ACID DERIVATIVE AND MEDICINE COMPRISING SALT OR ESTER OF THE SAME Eisai Co., Ltd. (JP) 2004-03-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040214888-A1 Carboxylic acid derivative and medicine comprising salt or ester of the same GPR119, NR3C1, INSR TSHR 322/4885RECQL 3023/4885MAPT 4765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.